Loading...
We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord
- Ticker
- HDST.TA
- Price
- 41.00
- Stock movement up
- +- (%)
- Company name
- Hadasit Bio
- Exchange
- (TA ,
- Currency
- ILA )
- Sector
- Healthcare >Biotechnology & Medical Research
- Market cap
- 454.63M
- Ent value
- 456.07M
- Price/Sales
- -
- Price/Book
- 41.54
- Div yield
- -
- Div growth
- -
- Growth years
- -
- FCF payout
- -
- Trailing P/E
- -
- Forward P/E
- -
- PEG
- -
- EPS growth
- -
- 1 year return
- -22.93%
- 3 year return
- -51.96%
- 5 year return
- -35.24%
- 10 year return
- -47.91%
Last updated: 2025-04-08
DIVIDENDS
HDST.TA does not pay dividends or no data was received
VALUATION
Valuation Ratios
Loading...
Valuation Ratios data
| Trailing P/E | - |
| Price to OCF | - |
| Price to FCF | - |
| Price to EBITDA | - |
| EV to EBITDA | - |
Valuation (Sales/Book Value)
Loading...
Valuation (Sales/Book Value) data
| Price to Sales | - |
| Price to Book | 41.54 |
| EV to Sales | - |
FINANCIALS
Per share
Loading...
Per share data
| Current share count | 11.09M |
| EPS (TTM) | - |
| FCF per share (TTM) | -0.07 |
Income statement
Loading...
Income statement data
| Revenue (TTM) | 0.00 |
| Gross profit (TTM) | 0.00 |
| Operating income (TTM) | 0.00 |
| Net income (TTM) | 0.00 |
| EPS (TTM) | - |
| EPS (1y forward) | - |
Margins
Loading...
Margins data
| Gross margin (TTM) | - |
| Operating margin (TTM) | - |
| Profit margin (TTM) | - |
Balance Sheet
Loading...
Please create a free account or log in to access this chart
Balance Sheet data
| Cash | 2.28M |
| Net receivables | 121.00K |
| Total current assets | 10.76M |
| Goodwill | 0.00 |
| Intangible assets | 0.00 |
| Property, plant and equipment | 0.00 |
| Total assets | 14.67M |
| Accounts payable | 178.00K |
| Short/Current long term debt | 0.00 |
| Total current liabilities | 2.19M |
| Total liabilities | 3.73M |
| Shareholder's equity | 10.94M |
| Net tangible assets | 0.00 |
Cash flow
Loading...
Please create a free account or log in to access this chart
Cash flow data
| Operating cash flow (TTM) | -721.00K |
| Capital expenditures (TTM) | 0.00 |
| Free cash flow (TTM) | -721.00K |
| Dividends paid (TTM) | 0.00 |
Financial returns
Loading...
Please create a free account or log in to access this chart
Financial returns data
| Return on Equity | - |
| Return on Assets | - |
| Return on Invested Capital | - |
| Cash Return on Invested Capital | -5.78% |
STOCK INFORMATION
Stock chart
Loading...
Stock price data
| Open | 41.00 |
| Daily high | 41.00 |
| Daily low | 41.00 |
| Daily Volume | 2K |
| All-time high | 1042945.42 |
| 1y analyst estimate | - |
| Beta | 0.58 |
| EPS (TTM) | - |
| Dividend per share | - |
| Ex-div date | 7 Feb 2019 |
| Next earnings date | - |
Downside potential
Loading...
Downside potential data
| HDST.TA | S&P500 | |
| Current price drop from All-time high | -100.00% | -17.71% |
| Highest price drop | -100.00% | -56.47% |
| Date of highest drop | 4 Nov 2024 | 9 Mar 2009 |
| Avg drop from high | -86.08% | -11.07% |
| Avg time to new high | 249 days | 12 days |
| Max time to new high | 4477 days | 1805 days |
COMPANY DETAILS
Marketcap
454.63M
Marketcap category
Small-cap
Description
HBL - Hadasit Bio-Holdings Ltd operates in the biotechnology industry in Israel. It operates in the fields of oncology, regenerative medicine, and inflammatory disease. The company develops biological drugs; and plasma RNA biomarkers for colorectal cancer. It offers ProtAb, an immunotherapeutic monoclonal antibody for the treatment of autoimmune inflammatory diseases. HBL - Hadasit Bio-Holdings Ltd was incorporated in 2005 and is based in Jerusalem, Israel.
Employees
2
Website
Investor relations
-
SEC filings
CEO
Country
Israel
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...
UNDERSTAND THE BUSINESS
Loading...
COMPANY NEWS
All newsPress releases
No items found